NASDAQ:THOR - Nasdaq -
NASDAQ:THOR (1/22/2020, 9:33:30 PM)
67.99
0 (0%)
The current stock price of THOR is 67.99 null. In the past month the price decreased by -0.04%. In the past year, price increased by 386.69%.
Synthorx Inc. is a biopharmaceutical company which focuses on cancer and autoimmune disorders. The company's product pipeline consists of THOR-707, IL-2 autoimmune synthorin, IL-10 synthorin and IL-15 synthorin which are in clinical stage. Synthorx Inc. is based in La Jolla, CA.
Synthorx INC
11099 North Torrey Pines Road Suite 190
La Jolla CA 92037
CEO: Laura Shawver
Phone: 858-750-4700
The current stock price of THOR is 67.99 null.
The exchange symbol of Synthorx INC is THOR and it is listed on the Nasdaq exchange.
THOR stock is listed on the Nasdaq exchange.
Synthorx INC (THOR) has a market capitalization of 2.20B null. This makes THOR a Mid Cap stock.
Synthorx INC (THOR) has a support level at 67.98 and a resistance level at 70.96. Check the full technical report for a detailed analysis of THOR support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
THOR does not pay a dividend.
Synthorx INC (THOR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.01).
ChartMill assigns a technical rating of 7 / 10 to THOR. When comparing the yearly performance of all stocks, THOR is one of the better performing stocks in the market, outperforming 99.83% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to THOR. No worries on liquidiy or solvency for THOR as it has an excellent financial health rating, but there are worries on the profitability.
Over the last trailing twelve months THOR reported a non-GAAP Earnings per Share(EPS) of -2.0100000000000002. The EPS decreased by -172.24% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -38.86% | ||
ROE | N/A | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 60% to THOR. The Buy consensus is the average rating of analysts ratings from 4 analysts.